MT-101(Morphic Therapeutic)

N/A

Report date: 2024/08/23 09:47:28

Base Information

Drug NameMT-101(Morphic Therapeutic)
Drug Alias NameNext Gen α4β7 Inhibitors Therapy(Morphic Therapeutic)MT-101(Morphic Therapeutic)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIntegrin alpha-4/beta-7 inhibitors
TargetsIntegrin alpha-4/beta-7
Therapy Area/IndicationsEosinophilic gastroenteritis (EG)PouchitisGastrointestinal Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMorphic Therapeutic Inc
China Registration ClassN/A

Develop Information

Active CompaniesMorphic Therapeutic Inc
Inactive CompaniesN/A
Active IndicationsEosinophilic gastroenteritis (EG)PouchitisGastrointestinal Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A